Report: Global market for peripheral vascular interventions will reach $3.4B by 2022
By 2022, the global market for lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons, carotid stents, renal stents and other peripheral vascular interventions will increase to $3.4 billion, up from $2.1 billion last year.
GlobalData, a research and consulting firm, provided the estimates in a report released this month titled “MediPoint: Peripheral Vascular Interventions – Global Analysis and Market Forecasts.”
The company noted that the market would increase as a result of recent advances such as drug-eluting stents and balloons, bioabsorbable stents and polytetrafluoroethylene-covered stents to treat peripheral artery disease.
This report includes data from North America (Canada, Mexico, US), Europe (France, Germany, Italy, Spain, Russia, UK), Asia-Pacific (Australia, China, India, Japan, South Korea) and South America (Brazil).
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.